141 related articles for article (PubMed ID: 30932446)
1. Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease.
Leone A; Manna R; Verrecchia E; Cipullo M; Rigante D
Reumatismo; 2019 Apr; 71(1):53-55. PubMed ID: 30932446
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation.
Rodriguez-Smith J; Lin YC; Tsai WL; Kim H; Montealegre-Sanchez G; Chapelle D; Huang Y; Sibley CH; Gadina M; Wesley R; Bielekova B; Goldbach-Mansky R
Arthritis Rheumatol; 2017 Jun; 69(6):1325-1336. PubMed ID: 28118536
[TBL] [Abstract][Full Text] [Related]
3. Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA).
Rigante D; Leone A; Marrocco R; Laino ME; Stabile A
Rheumatol Int; 2011 Dec; 31(12):1661-4. PubMed ID: 21240490
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy.
Kim YH; Kim BJ; Han J; Choi BY; Lee S
J Clin Immunol; 2021 Nov; 41(8):1936-1939. PubMed ID: 34346012
[No Abstract] [Full Text] [Related]
5. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.
Kuemmerle-Deschner JB; Wittkowski H; Tyrrell PN; Koetter I; Lohse P; Ummenhofer K; Reess F; Hansmann S; Koitschev A; Deuter C; Bialkowski A; Foell D; Benseler SM
Arthritis Res Ther; 2013; 15(3):R64. PubMed ID: 23718630
[TBL] [Abstract][Full Text] [Related]
6. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.
Sibley CH; Plass N; Snow J; Wiggs EA; Brewer CC; King KA; Zalewski C; Kim HJ; Bishop R; Hill S; Paul SM; Kicker P; Phillips Z; Dolan JG; Widemann B; Jayaprakash N; Pucino F; Stone DL; Chapelle D; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
Arthritis Rheum; 2012 Jul; 64(7):2375-86. PubMed ID: 22294344
[TBL] [Abstract][Full Text] [Related]
7. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.
Mulders-Manders CM; Kanters TA; van Daele PLA; Hoppenreijs E; Legger GE; van Laar JAM; Simon A; Hakkaart-van Roijen L
Orphanet J Rare Dis; 2018 Apr; 13(1):59. PubMed ID: 29678136
[TBL] [Abstract][Full Text] [Related]
8. Switch from anakinra to canakinumab in a severe case of CINCA syndrome.
Rigante D; Verrecchia E; Falsini B; Manna R
Int J Rheum Dis; 2016 Dec; 19(12):1354-1356. PubMed ID: 26585548
[No Abstract] [Full Text] [Related]
9. Neonatal urticaria: Could it be CAPS?
Cutts L; Parslew R; Eustace K
Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
[TBL] [Abstract][Full Text] [Related]
10. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
[TBL] [Abstract][Full Text] [Related]
11. Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
Aït-Abdesselam T; Lequerré T; Legallicier B; François A; Le Loët X; Vittecoq O
Joint Bone Spine; 2010 Dec; 77(6):616-7. PubMed ID: 20609610
[No Abstract] [Full Text] [Related]
12. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
Wohlrab F; Bauknecht C; Meisel C; Dreier JP
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):e1-3. PubMed ID: 33109682
[No Abstract] [Full Text] [Related]
13. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
Landmann EC; Walker UA
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
[TBL] [Abstract][Full Text] [Related]
14. Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study.
Wikén M; Hallén B; Kullenberg T; Koskinen LO
Clin Rheumatol; 2018 Dec; 37(12):3381-3386. PubMed ID: 29982913
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.
Kullenberg T; Löfqvist M; Leinonen M; Goldbach-Mansky R; Olivecrona H
Rheumatology (Oxford); 2016 Aug; 55(8):1499-506. PubMed ID: 27143789
[TBL] [Abstract][Full Text] [Related]
17. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
18. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS).
Chang Z; Spong CY; Jesus AA; Davis MA; Plass N; Stone DL; Chapelle D; Hoffmann P; Kastner DL; Barron K; Goldbach-Mansky RT; Stratton P
Arthritis Rheumatol; 2014 Nov; 66(11):3227-32. PubMed ID: 25223501
[TBL] [Abstract][Full Text] [Related]
19. Auto-Inflammatory Syndromes Revealing Hematological Disorders and Anakinra Efficacy in 2 Cases.
Brevet P; Curie A; Princivil C; Zarnitsky C; Alcaix D
J Clin Rheumatol; 2021 Dec; 27(8S):S403-S404. PubMed ID: 32496361
[No Abstract] [Full Text] [Related]
20. Muckle-Wells treatment with anakinra.
Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
